Prof. Scott T. Tagawa

Professor Scott Tagawa is the Professor of Medicine and Urology at Weill Cornell Medicine, and an attending physician at New York-Presbyterian – Weill Cornell Medical Center. Prof. Tagawa received his MD at the University of Southern California School of Medicine. He was appointed as Assistant Professor of Medicine at Mount Sinai School of Medicine in August 2005, and later in 2007, he was recruited to Weill Cornell Medical College. His research interests include clinical and translational investigations in genitourinary tumors (prostate, kidney, and bladder cancer) and thrombosis in malignancy. He has a particular interest in the development of therapeutics and diagnostics targeting cell-surface antigens. Prof. Tagawa serves as medical director of the Genitourinary Research Program at Weill Cornell medicine, and leader of the GU Disease Management Team and co-leader of the Experimental Therapeutics Program of the Meyer Cancer Center. He is the WCMC principal investigator for the Alliance for Clinical Trials in Oncology (formerly CALGB), serving on the board of directors. He is a former leader of the Evidence Based Medicine Committee for ASCO and serves on the editorial boards of various reputed journals.
Connect with me on LinkedIn

Supported by

                      Join the conversation #apcc24  Connect with us on LinkedIn